{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T12:28:14Z","timestamp":1768566494276,"version":"3.49.0"},"reference-count":30,"publisher":"Archives of Endocrinology and Metabolism","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.20945\/2359-3997000000033","type":"journal-article","created":{"date-parts":[[2018,6,20]],"date-time":"2018-06-20T19:41:53Z","timestamp":1529523713000},"page":"264-269","source":"Crossref","is-referenced-by-count":10,"title":["What determines mortality in malignant pheochromocytoma? \u2013 Report of a case with eighteen-year survival and review of the literature"],"prefix":"10.20945","volume":"62","author":[{"given":"Matheus de Oliveira","family":"Andrade","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vin\u00edcius Santos da","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dayana Carla de","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ol\u00edvia Laquis de","family":"Moraes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Lofrano-Porto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8510","published-online":{"date-parts":[[2018,4]]},"reference":[{"issue":"6","key":"key20180620153914_B1","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Endocrine Society. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","unstructured":"1. Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH, et al.; Endocrine Society. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(6):1915-42.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"key20180620153914_B2","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.amjsurg.2010.04.012","article-title":"Malignant pheochromocytoma: a review","volume":"201","author":"Harari","year":"2011","unstructured":"2. Harari A, Inabnet WB 3rd. Malignant pheochromocytoma: a review. Am J Surg. 2011;201(5):700-8.","journal-title":"Am J Surg"},{"issue":"9","key":"key20180620153914_B3","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1055\/s-0029-1231025","article-title":"Treatment of malignant pheochromocytoma","volume":"41","author":"Adjall\u00e9","year":"2009","unstructured":"3. Adjall\u00e9 R, Plouin PF, Pacak K, Lehnert H. Treatment of malignant pheochromocytoma. Horm Metab Res. 2009;41(9):687-96.","journal-title":"Horm Metab Res"},{"issue":"3","key":"key20180620153914_B4","doi-asserted-by":"crossref","first-page":"R111","DOI":"10.1530\/EJE-14-0113","article-title":"Therapy of endocrine disease: treatment of malignant pheochromocytoma and paraganglioma","volume":"171","author":"Baudin","year":"2014","unstructured":"4. Baudin E, Habra MA, Deschamps F, Cote G, Dumont F, Cabanillas M, et al. Therapy of endocrine disease: treatment of malignant pheochromocytoma and paraganglioma. Eur J Endocrinol. 2014;171(3):R111-22.","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"key20180620153914_B5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168413","article-title":"Disentangling of malignancy from benign pheochromocytomas\/paragangliomas","volume":"11","author":"Kim","year":"2016","unstructured":"5. Kim KY, Kim JH, Hong AR, Seong MW, Lee KE, Kim SJ, et al. Disentangling of malignancy from benign pheochromocytomas\/paragangliomas. PLoS One. 2016;11(12):e0168413.","journal-title":"PLoS One"},{"issue":"3","key":"key20180620153914_B6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1442-2042.2007.01687.x","article-title":"Clinical and pathological data of 10 malignant pheochromocytomas: long-term follow up in a single institute","volume":"14","author":"Huang","year":"2007","unstructured":"6. Huang KH, Chung SD, Chen SC, Chueh SC, Pu YS, Lai MK, et al. Clinical and pathological data of 10 malignant pheochromocytomas: long-term follow up in a single institute. Int J Urol. 2007;14(3):181-5.","journal-title":"Int J Urol"},{"issue":"2","key":"key20180620153914_B7","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1055\/s-0032-1331217","article-title":"Mortality associated with phaeochromocytoma","volume":"45","author":"Prejbisz","year":"2013","unstructured":"7. Prejbisz A, Lenders JW, Eisenhofer G, Januszewicz A. Mortality associated with phaeochromocytoma. Horm Metab Res. 2013;45(2):154-8.","journal-title":"Horm Metab Res"},{"issue":"8","key":"key20180620153914_B8","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/jso.24063","article-title":"Clinical course and prognostic factors in patients with malignant pheochromocytoma and paraganglioma: A single institution experience","volume":"112","author":"Choi","year":"2015","unstructured":"8. Choi YM, Sung TY, Kim WG, Lee JJ, Ryu JS, Kim TY, et al. Clinical course and prognostic factors in patients with malignant pheochromocytoma and paraganglioma: A single institution experience. J Surg Oncol. 2015;112(8):815-21.","journal-title":"J Surg Oncol"},{"issue":"5","key":"key20180620153914_B9","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1378\/chest.58.5.546","article-title":"Malignant pheochromocytoma with pleural metastasis of unusually long duration","volume":"58","author":"Traub","year":"1970","unstructured":"9. Traub YM, Rosenfeld JB. Malignant pheochromocytoma with pleural metastasis of unusually long duration. Chest. 1970;58(5):546-50.","journal-title":"Chest"},{"issue":"2","key":"key20180620153914_B10","first-page":"97","article-title":"Current management of pheochromocytoma","volume":"34","author":"Remine","year":"1975","unstructured":"10. Remine WH, Chong GC, Van Heerden JA, Sheps SG, Harrison EG. Current management of pheochromocytoma. Bull Soc Int Chir. 1975;34(2):97-8.","journal-title":"Bull Soc Int Chir"},{"issue":"6","key":"key20180620153914_B11","first-page":"245","article-title":"Prolonged survival in a patient with pulmonary metastases of a malignant pheochromocytoma","volume":"21","author":"van den Broek","year":"1978","unstructured":"11. van den Broek PJ, de Graeff J. Prolonged survival in a patient with pulmonary metastases of a malignant pheochromocytoma. Neth J Med. 1978;21(6):245-7.","journal-title":"Neth J Med"},{"issue":"5","key":"key20180620153914_B12","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0002-9610(80)90061-6","article-title":"Multiple sequential pulmonary resections for metastatic pheochromocytoma with long-term survival","volume":"140","author":"Abemayor","year":"1980","unstructured":"12. Abemayor E, Harken AH, Koop CE. Multiple sequential pulmonary resections for metastatic pheochromocytoma with long-term survival. Am J Surg. 1980;140(5):696-7.","journal-title":"Am J Surg"},{"issue":"4","key":"key20180620153914_B13","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/BF01657665","article-title":"Persistent and recurrent pheochromocytoma: The role of surgery","volume":"6","author":"Brennan","year":"1982","unstructured":"13. Brennan MF, Kaiser HR. Persistent and recurrent pheochromocytoma: The role of surgery. World J Surg. 1982;6(4):397-401.","journal-title":"World J Surg"},{"issue":"6","key":"key20180620153914_B14","first-page":"1221","article-title":"[A long survived case of malignant pheochromocytoma treated with alpha-methyl-p-tyrosine and midaglizol (DG-5128)]","volume":"25","author":"Okada","year":"1990","unstructured":"14. Okada S, Ohshima K, Onai T, Umahara M, Kobayashi S, Ishihara H. [A long survived case of malignant pheochromocytoma treated with alpha-methyl-p-tyrosine and midaglizol (DG-5128)]. Nihon Gan Chiryo Gakkai Shi. 1990;25(6):1221-5.","journal-title":"Nihon Gan Chiryo Gakkai Shi"},{"issue":"9","key":"key20180620153914_B15","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/BF03345808","article-title":"Malignant pheochromocytoma: a series of 14 cases observed between 1966 and 1990","volume":"15","author":"Mornex","year":"1992","unstructured":"15. Mornex R, Badet C, Peyrin L. Malignant pheochromocytoma: a series of 14 cases observed between 1966 and 1990. J Endocrinol Invest. 1992;15(9):643-9.","journal-title":"J Endocrinol Invest"},{"issue":"10","key":"key20180620153914_B16","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/s004020100305","article-title":"Twenty-six-years' survival with multiple bone metastasis of malignant pheochromocytoma","volume":"121","author":"Yoshida","year":"2001","unstructured":"16. Yoshida S, Hatori M, Noshiro T, Kimura N, Kokubun S. Twenty-six-years' survival with multiple bone metastasis of malignant pheochromocytoma. Arch Orthop Trauma Surg. 2001;121(10):598-600.","journal-title":"Arch Orthop Trauma Surg"},{"issue":"9","key":"key20180620153914_B17","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1210\/jc.2002-020312","article-title":"Familial malignant catecholamine-secreting paraganglioma with prolonged survival associated with mutation in the succinate dehydrogenase B gene","volume":"87","author":"Young","year":"2002","unstructured":"17. Young AL, Baysal BE, Deb A, Young WF Jr. Familial malignant catecholamine-secreting paraganglioma with prolonged survival associated with mutation in the succinate dehydrogenase B gene. J Clin Endocrinol Metab. 2002;87(9):4101-5.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"key20180620153914_B18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4158\/EP.9.1.45","article-title":"Prolonged survival of a patient with multiple endocrine neoplasia type 2b and stage IV medullary thyroid carcinoma","volume":"9","author":"M\u00f3zes","year":"2003","unstructured":"18. M\u00f3zes G, van Heerden JA, Gharib H. Prolonged survival of a patient with multiple endocrine neoplasia type 2b and stage IV medullary thyroid carcinoma. Endocr Pract. 2003;9(1):45-51.","journal-title":"Endocr Pract"},{"issue":"10","key":"key20180620153914_B19","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.1210\/jc.2004-2290","article-title":"Repeated [131I]metaiodobenzylguanidine therapy in two patients with malignant pheochromocytoma","volume":"90","author":"Lam","year":"2005","unstructured":"19. Lam MG, Lips CJ, Jager PL, Dullaart RP, Lentjes EG, van Rijk PP, et al. Repeated [131I]metaiodobenzylguanidine therapy in two patients with malignant pheochromocytoma. J Clin Endocrinol Metab. 2005;90(10):5888-95.","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180620153914_B20","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1196\/annals.1353.053","article-title":"Courses of malignant pheochromocytoma: implications for therapy","volume":"1073","author":"Sisson","year":"2006","unstructured":"20. Sisson JC, Shulkin BL, Esfandiari NH. Courses of malignant pheochromocytoma: implications for therapy. Ann N Y Acad Sci. 2006;1073:505-11.","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"key20180620153914_B21","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s12020-010-9422-5","article-title":"Malignant pheochromocytoma: predictive factors of malignancy and clinical course in 16 patients at a single tertiary medical center","volume":"39","author":"Szalat","year":"2011","unstructured":"21. Szalat A, Fraenkel M, Doviner V, Salmon A, Gross DJ. Malignant pheochromocytoma: predictive factors of malignancy and clinical course in 16 patients at a single tertiary medical center. Endocrine. 2011;39(2):160-6.","journal-title":"Endocrine"},{"issue":"5","key":"key20180620153914_B22","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/qjmed\/hcu208","article-title":"Management of metastatic phaeochromocytoma and paraganglioma: use of iodine-131-meta-iodobenzylguanidine therapy in a tertiary referral centre","volume":"108","author":"Rutherford","year":"2015","unstructured":"22. Rutherford MA, Rankin AJ, Yates TM, Mark PB, Perry CG, Reed NS, et al. Management of metastatic phaeochromocytoma and paraganglioma: use of iodine-131-meta-iodobenzylguanidine therapy in a tertiary referral centre. QJM. 2015;108(5):361-8.","journal-title":"QJM"},{"issue":"Suppl. 2","key":"key20180620153914_B23","article-title":"Long-term survival in a patient with head and neck paraganglioma treated with tailored modalities for 20 years: a case report","volume":"102","author":"Belgioia","year":"2016","unstructured":"23. Belgioia L, Pupillo F, Bacigalupo A, Corv\u00f2 R. Long-term survival in a patient with head and neck paraganglioma treated with tailored modalities for 20 years: a case report. Tumori. 2016;102(Suppl. 2).","journal-title":"Tumori"},{"issue":"11","key":"key20180620153914_B24","first-page":"575","article-title":"[Treatment of malignant pheochromocytoma with 131I MIBG: a long survival]","volume":"20","author":"Arias Martinez","year":"2003","unstructured":"24. Arias Martinez N, Barbado Hernandez FJ, Couto Caro R, Gil Guerrero L, Coronado Arias Mart\u00ednez N, Barbado Hern\u00e1ndez FJ, Couto Caro R, Gil Guerrero L, Coronado Poggio M, Navarro T, et al. [Treatment of malignant pheochromocytoma with 131I MIBG: a long survival]. An Med Interna. 2003;20(11):575-8.","journal-title":"An Med Interna"},{"issue":"3","key":"key20180620153914_B25","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1373\/clinchem.2010.153320","article-title":"Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma","volume":"57","author":"Eisenhofer","year":"2011","unstructured":"25. Eisenhofer G, Lenders JW, Timmers H, Mannelli M, Grebe SK, Hofbauer LC, et al. Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma. Clin Chem. 2011;57(3):411-20.","journal-title":"Clin Chem"},{"issue":"2","key":"key20180620153914_B26","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrendo.2014.188","article-title":"Paraganglioma and phaeochromocytoma: from genetics to personalized medicine","volume":"11","author":"Favier","year":"2015","unstructured":"26. Favier J, Amar L, Gimenez-Roqueplo AP. Paraganglioma and phaeochromocytoma: from genetics to personalized medicine. Nat Rev Endocrinol. 2015;11(2):101-11.","journal-title":"Nat Rev Endocrinol"},{"issue":"6","key":"key20180620153914_B27","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1245\/s10434-016-5739-5","article-title":"Surgical treatment of malignant pheochromocytoma and paraganglioma: retrospective case series","volume":"24","author":"Strajina","year":"2017","unstructured":"27. Strajina V, Dy BM, Farley DR, Richards ML, McKenzie TJ, Bible KC, et al. Surgical treatment of malignant pheochromocytoma and paraganglioma: retrospective case series. Ann Surg Oncol. 2017;24(6):1546-50.","journal-title":"Ann Surg Oncol"},{"issue":"25","key":"key20180620153914_B28","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1200\/JCO.2008.21.3496","article-title":"Phase II study of high-dose [131I]metaiodobenzylguanidine therapy for patients with metastatic pheochromocytoma and paraganglioma","volume":"27","author":"Gonias","year":"2009","unstructured":"28. Gonias S, Goldsby R, Matthay KK, Hawkins R, Price D, Huberty J, et al. Phase II study of high-dose [131I]metaiodobenzylguanidine therapy for patients with metastatic pheochromocytoma and paraganglioma. J Clin Oncol. 2009;27(25):4162-8.","journal-title":"J Clin Oncol"},{"issue":"6","key":"key20180620153914_B29","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0039-6060(03)00426-4","article-title":"Iodine-131 metaiodobenzylguanidine is an effective treatment for malignant pheochromocytoma and paraganglioma","volume":"134","author":"Safford","year":"2003","unstructured":"29. Safford SD, Coleman RE, Gockerman JP, Moore J, Feldman JM, Leight GS Jr, et al. Iodine-131 metaiodobenzylguanidine is an effective treatment for malignant pheochromocytoma and paraganglioma. Surgery. 2003;134(6):956-62.","journal-title":"Surgery"},{"issue":"5","key":"key20180620153914_B30","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.ejso.2004.03.006","article-title":"Mortality associated with pheochromocytoma in a large Swedish cohort","volume":"30","author":"Khorram-Manesh","year":"2004","unstructured":"30. Khorram-Manesh A, Ahlman H, Nilsson O, Od\u00e9n A, Jansson S. Mortality associated with pheochromocytoma in a large Swedish cohort. Eur J Surg Oncol. 2004;30(5):556-9.","journal-title":"Eur J Surg Oncol"}],"container-title":["Archives of Endocrinology and Metabolism"],"original-title":[],"language":"en","deposited":{"date-parts":[[2018,6,20]],"date-time":"2018-06-20T19:41:58Z","timestamp":1529523718000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S2359-39972018000200264&lng=en&nrm=iso&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,4]]}},"alternative-id":["10.20945\/2359-3997000000033"],"URL":"https:\/\/doi.org\/10.20945\/2359-3997000000033","relation":{},"ISSN":["2359-3997","2359-4292"],"issn-type":[{"value":"2359-3997","type":"print"},{"value":"2359-4292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4]]}}}